| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_630f924c1eea9d4921e893ad6c349c9b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-96444
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2400-40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-54393
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-56 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86 |
| filingDate |
2006-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6a8e7bc7ec93649501a91055c7fac70e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_529efdf06a85ea8a84994f5a78250a28 |
| publicationDate |
2007-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1752772-A1 |
| titleOfInvention |
Assay for determination of heparin based on factor Xa using a heparin-modifying component |
| abstract |
The present invention is in the field of coagulation diagnostics and relates to a method for determining heparin activity in a sample, wherein the sample is first incubated with a heparin-modifying moiety such as heparinase, and then the heparin-dependent FXa inactivation is measured. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3348649-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008012044-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2018130676-A1 |
| priorityDate |
2005-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |